Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected mice.

Weinstein EA, Liu L, Ordonez AA, Wang H, Hooker JM, Tonge PJ, Jain SK.

Antimicrob Agents Chemother. 2012 Dec;56(12):6284-90. doi: 10.1128/AAC.01644-12. Epub 2012 Sep 24. Erratum in: Antimicrob Agents Chemother. 2013 Jan;57(1):678.


Novel synthesis of 2-[18F]-fluoroisonicotinic acid hydrazide and initial biological evaluation.

Amartey JK, Al-Jammaz I, Al-Otaibi B, Esguerra C.

Nucl Med Biol. 2002 Nov;29(8):817-23.


2-[(18)F]-fluoroisonicotinic acid hydrazide: biological evaluation in an acute infection model.

Amartey JK, Esguerra C, Al-Otaibi B, Parhar RS, Al-Jammaz I.

Appl Radiat Isot. 2004 Jun;60(6):839-43.


Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

Davis SL, Nuermberger EL, Um PK, Vidal C, Jedynak B, Pomper MG, Bishai WR, Jain SK.

Antimicrob Agents Chemother. 2009 Nov;53(11):4879-84. doi: 10.1128/AAC.00789-09. Epub 2009 Sep 8.


Imaging Chronic Tuberculous Lesions Using Sodium [(18)F]Fluoride Positron Emission Tomography in Mice.

Ordonez AA, DeMarco VP, Klunk MH, Pokkali S, Jain SK.

Mol Imaging Biol. 2015 Oct;17(5):609-14. doi: 10.1007/s11307-015-0836-6.


Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging.

DeMarco VP, Ordonez AA, Klunk M, Prideaux B, Wang H, Zhuo Z, Tonge PJ, Dannals RF, Holt DP, Lee CK, Weinstein EA, Dartois V, Dooley KE, Jain SK.

Antimicrob Agents Chemother. 2015 Sep;59(9):5768-74. doi: 10.1128/AAC.01146-15. Epub 2015 Jul 13.


Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.

Via LE, Schimel D, Weiner DM, Dartois V, Dayao E, Cai Y, Yoon YS, Dreher MR, Kastenmayer RJ, Laymon CM, Carny JE, Flynn JL, Herscovitch P, Barry CE 3rd.

Antimicrob Agents Chemother. 2012 Aug;56(8):4391-402. doi: 10.1128/AAC.00531-12. Epub 2012 Jun 11.


Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.

Sathekge M, Maes A, D'Asseler Y, Vorster M, Van de Wiele C.

Nucl Med Commun. 2012 Jun;33(6):581-90. doi: 10.1097/MNM.0b013e3283528a7c. Review.


11C-Labeled isoniazid.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Oct 1].


Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET.

Murawski AM, Gurbani S, Harper JS, Klunk M, Younes L, Jain SK, Jedynak BM.

J Nucl Med. 2014 Oct;55(10):1726-9. doi: 10.2967/jnumed.114.144634. Epub 2014 Jul 31.


Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice.

Ordonez AA, Pokkali S, DeMarco VP, Klunk M, Mease RC, Foss CA, Pomper MG, Jain SK.

Antimicrob Agents Chemother. 2015 Jan;59(1):642-9. doi: 10.1128/AAC.04180-14. Epub 2014 Nov 17.


[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.


11C-Labeled rifampicin.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Sep 1].


Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.

Mata-Espinosa D, Molina-Salinas GM, Barrios-Payán J, Navarrete-Vázquez G, Marquina B, Ramos-Espinosa O, Bini EI, Baeza I, Hernández-Pando R.

Pulm Pharmacol Ther. 2015 Jun;32:7-14. doi: 10.1016/j.pupt.2015.03.004. Epub 2015 Apr 2.


Novel amphiphilic probes for [18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography.

Urakami T, Akai S, Katayama Y, Harada N, Tsukada H, Oku N.

J Med Chem. 2007 Dec 27;50(26):6454-7. Epub 2007 Dec 1.


18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1213-22. doi: 10.1016/j.jcmg.2009.04.016.


Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.

Almeida D, Nuermberger E, Tasneen R, Rosenthal I, Tyagi S, Williams K, Peloquin C, Grosset J.

Antimicrob Agents Chemother. 2009 Oct;53(10):4178-84. doi: 10.1128/AAC.00830-09. Epub 2009 Jul 20.


5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.

Krämer SD, Mu L, Müller A, Keller C, Kuznetsova OF, Schweinsberg C, Franck D, Müller C, Ross TL, Schibli R, Ametamey SM.

J Nucl Med. 2012 Mar;53(3):434-42. doi: 10.2967/jnumed.111.096289. Epub 2012 Feb 13.


Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

Dutta NK, Pinn ML, Karakousis PC.

Antimicrob Agents Chemother. 2014 Jul;58(7):4048-53. doi: 10.1128/AAC.02981-14. Epub 2014 May 5.

Supplemental Content

Support Center